Skip to main content
HealthReportedMedium
4.8

1 in 10 US adults report GLP-1 use in past year, STAT survey finds

A STAT survey indicates that during July-August 2025, roughly 10% of U.S. adults reported taking a GLP-1 medication in the prior year, reflecting significant uptake of these drugs. The finding underscores the expanding market for GLP-1s beyond diabetes into weight management, with implications for healthcare costs and pharmaceutical demand. The survey is self-reported and may overstate or understate actual use, but it signals a major shift in treatment patterns.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

STAT Newsabout 8 hours agoUSengCredibility 19%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.2

Intelligence Tags

Entities

United Statescountry
Source

Related signals

8 found